Aster DM Healthcare Ltd

Aster DM Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aster DM Healthcare Ltd

₹ 555 -4.28%
21 May 12:32 p.m.
asterdmhealthcare.com BSE: 540975 NSE: ASTERDM
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Business Segments Q1 FY25
1) Hospitals and Clinics (94%): The company has a network of 19 hospitals (vs 14 hospitals in FY22) and 13 clinics. These hospitals are located in the Maharastra (1), Karnataka (4), Kerala (6), Andhra (6) & Telangana (1). [1]

This business has registered a 23% YoY revenue growth and EBITDA grew by 28% in FY24, on the backdrop of an increased bed capacity of 550 beds, and cost optimization measures. Material cost has declined from 25% in FY22 to 22% in FY24. [2] [3]

Website BSE NSE
  • Market Cap ₹ 27,713 Cr.
  • Current Price ₹ 555
  • High / Low ₹ 610 / 311
  • Stock P/E 69.4
  • Book Value ₹ 68.6
  • Dividend Yield 0.71 %
  • ROCE 10.7 %
  • ROE 10.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 63.8%
  • Debtor days have improved from 110 to 22.7 days.

Cons

  • Stock is trading at 8.05 times its book value
  • Promoter holding has decreased over last quarter: -1.50%
  • The company has delivered a poor sales growth of -13.7% over past five years.
  • Company has a low return on equity of 8.10% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoters have pledged 40.7% of their holding.
  • Earnings include an other income of Rs.5,169 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
2,728 2,662 2,816 3,192 807 841 929 955 974 1,002 1,086 1,050 1,000
2,267 2,370 2,498 2,743 687 722 787 805 817 841 869 864 818
Operating Profit 460 292 319 449 120 119 142 149 156 161 217 186 182
OPM % 17% 11% 11% 14% 15% 14% 15% 16% 16% 16% 20% 18% 18%
22 37 18 10 149 -17 -64 153 -40 5,120 35 9 5
Interest 62 69 77 87 25 25 30 25 30 29 31 31 32
Depreciation 170 175 189 198 54 51 54 57 58 60 62 62 64
Profit before tax 250 85 71 173 190 26 -7 220 28 5,191 159 102 91
Tax % 2% 6% 23% 8% 4% 24% 120% 5% 108% 1% 33% 37% 6%
246 80 54 159 183 20 -15 209 -2 5,152 106 64 86
EPS in Rs 4.53 1.37 0.93 2.79 3.42 0.10 -0.62 3.59 -0.48 103.00 1.94 1.14 1.58
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2,871 3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 2,994 3,699 4,138
2,421 3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 2,547 3,124 3,393
Operating Profit 451 506 445 349 632 1,077 1,465 1,103 1,533 447 575 746
OPM % 16% 13% 8% 6% 9% 14% 17% 13% 15% 15% 16% 18%
19 23 25 453 177 -155 -158 53 51 353 32 5,169
Interest 48 79 189 371 204 205 391 334 307 96 119 124
Depreciation 111 144 243 322 298 306 586 618 641 192 220 249
Profit before tax 310 306 38 108 308 410 330 205 637 511 268 5,542
Tax % 9% 11% 78% 10% 8% 10% 5% 13% 6% 7% 21% 2%
284 272 8 98 282 367 315 178 601 475 212 5,408
EPS in Rs 4.69 7.00 0.20 2.52 5.32 6.59 5.54 2.96 10.53 8.51 2.59 107.66
Dividend Payout % 35% 0% 0% 0% 0% 0% 0% 0% 0% 0% 77% 114%
Compounded Sales Growth
10 Years: 1%
5 Years: -14%
3 Years: -26%
TTM: 12%
Compounded Profit Growth
10 Years: 4%
5 Years: -2%
3 Years: -9%
TTM: 209%
Stock Price CAGR
10 Years: %
5 Years: 45%
3 Years: 49%
1 Year: 61%
Return on Equity
10 Years: 8%
5 Years: 9%
3 Years: 8%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 375 389 403 403 505 505 497 497 500 500 500 500
Reserves 536 1,096 17 1,472 2,327 2,709 2,775 2,875 3,080 3,574 3,686 2,929
886 1,091 3,321 2,758 2,352 2,788 5,605 4,804 5,282 6,075 1,758 2,018
1,097 1,834 2,003 2,171 2,296 2,926 3,528 3,444 3,661 4,687 12,039 1,161
Total Liabilities 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,606
1,087 2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 9,052 3,175 3,922
CWIP 357 197 358 290 402 550 736 934 998 279 170 291
Investments 7 3 39 32 38 22 34 63 45 80 17 245
1,442 1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 5,425 14,620 2,148
Total Assets 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 14,836 17,983 6,606

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
236 203 361 537 601 1,223 1,569 1,314 1,834 158 425
-439 -775 -1,136 -522 -702 -658 -333 -563 -951 -878 6,015
203 578 654 46 134 -675 -1,116 -686 -817 1,053 -6,358
Net Cash Flow -1 5 -122 61 33 -110 120 65 66 332 82

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 86 83 93 79 84 93 100 86 72 285 23 23
Inventory Days 71 93 92 102 111 110 138 122 129 612 44 36
Days Payable 176 178 187 151 150 153 303 290 267 1,400 183 166
Cash Conversion Cycle -18 -2 -1 30 45 50 -65 -83 -66 -503 -116 -107
Working Capital Days 61 69 68 57 59 57 40 38 40 129 297 -15
ROCE % 18% 14% 6% 1% 7% 13% 12% 6% 10% 3% 4% 11%

Shareholding Pattern

Numbers in percentages

7 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Apr 2025
37.88% 37.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.88% 41.89% 40.38%
11.77% 42.49% 38.63% 38.82% 40.22% 41.00% 33.48% 27.08% 23.86% 22.62% 21.66% 23.62%
8.99% 8.93% 8.93% 8.62% 7.64% 7.15% 13.70% 16.35% 20.91% 22.91% 24.58% 24.63%
40.91% 10.25% 10.12% 10.26% 9.85% 9.61% 10.59% 14.38% 13.05% 12.30% 11.60% 11.11%
0.45% 0.44% 0.43% 0.42% 0.41% 0.37% 0.35% 0.32% 0.30% 0.28% 0.26% 0.00%
No. of Shareholders 80,91384,57382,12971,37967,67367,33180,9312,06,6601,74,1711,59,0381,54,0141,51,664

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls